1. Grabowski Ł, Kończak-Czarnoczyńska K. Psychopathological analysis of several functional disorders and neurovegetative dysfunctions. Neuropsychiatr Neuropsychol 2022; 17: 9–15.
2.
Fink P, Toft T, Hansen MS, et al. Symptoms and syndromes of bodily distress: An exploratory study of 978 internal medical, neurological, and primary care patients. Psychosom Med 2007; 69: 30–39.
3.
Budtz-Lilly A, Schröder A, Rask MT, et al. Bodily distress syndrome: A new diagnosis for functional disorders in primary care? BMC Fam Pract Care 2015; 16: 180.
4.
Paul O. Da Costa’s syndrome or neurocirculatory asthenia. Br Heart J 1987; 58: 306–315.
5.
Fava GA, Magelli C, Savron G, et al. Neurocirculatory asthenia: a reassessment using modern psychosomatic criteria. Acta Psychiatrica Scandinavica 1994; 89: 314–319, doi: 10.1111/j.1600-0447.1994.tb01521.x.
6.
Da Costa JM. On irritable heart. Am J Med Sci 1871; 61: 17–52.
7.
Wooley CF. From irritable heart to mitral valve prolapse: World War I, the U.S. experience and the origin of neurocirculatory asthenia. Am J Cardiol 1987; 59: 1183–1186.
8.
Frohlich ED, Dustan HP, Page IH. Hyperdynamic beta-adrenergic circulatory state. Arch Intern Med 1966; 117: 614–619.
9.
Frishman WH. β-Adrenoceptor Blockade in Anxiety States: A New Approach to Therapy? In: Frishman WH, ed. Clinical Pharmacology of the β-Adrenoceptor Blocking Drugs. New York: Appelton-Century-Crofts; 1984: 479–500.
10.
Gorlin R. The hyperkinetic heart syndrome. JAMA 1962; 182: 823–829.
11.
Ockene IS, Shay MJ, Alpert JS, et al. Unexplained chest pain in patients with normal arteriograms. N Engl J Med 1980; 303: 1249–1252.
12.
Shader RI, Good MI, Greenblatt DJ. Anxiety states and beta-adrenergic blockade. In: Klein DF, Gittleman-Klein, eds. Progress in Psychiatric Drug Treatment. Brunner Mazel; 1976.
13.
Wheeler EO, White PD, Reed EW, et al. Neurocirculatory asthenia (anxiety neurosis, effort syndrome, neurasthenia). JAMA 1950; 142: 878–889.
14.
White PD, Cohen ME, Chapman WP. The electrocardiogram in neurocirculatory asthenia, anxiety neurosis or effort syndrome. Am Heart J 1947; 34: 390–394.
15.
Cohen ME, White PD. Life situations, emotions and neurocirculatory asthenia (anxiety neurosis, neurasthenia, effort syndrome). Psychosom Med 1951; 13: 335–357.
16.
Cohen ME, Johnson RE, Chapman WP, et al. A study of neurocirculatory asthenia, anxiety neurosis, effort syndrome. Final report to the Committee on Medical Research. Office of Scientific Research & Development; 1946.
17.
Peyritz RE. The Marfan syndrome. Ann Rev Med 2000; 51: 481–510.
18.
Thacoor A. Mitral valve prolapse and Marfan syndrome. Congenit Heart Dis 2017; 12: 430–434.
19.
Gottlieb SH. Mitral valve prolapse syndrome: from syndrome to disease. Am J Cardiol 1987; 60: 53J–58J.
20.
Conti S, Savron G, Bartolucci G, et al. Cardiac Neurosis and Psychopathology. Psychother Psychosom 1989; 52: 88–91.
21.
Fava GA, Grandi S, Canestrari R. Prodromal symptoms in panic disorders with agoraphobia. Am J Psychiatry 1988; 145: 1564–1567.
22.
Cohen ME, White PD, Johnson RE. Neurocirculatory asthenia, anxiety neurosis or the effort syndrome. Arch Intern Med 1948; 81: 260–281.
23.
Nijenhuis ER, Dyck R, van, Kuile MM, et al. Evidence for associations among somatoform dissociations, psychological dissociation and reported trauma in patients with chronic plevic pain. J Psychosom Obstet Gynecol 2003; 24: 87–98.
24.
Wearne D, Genetti A. Pseudohallucinations versus hallucinations: wherein lies the difference? Australas Psychiatry 2015; 23: 254–257.
25.
Grabowski Ł. Psychopatologia objawów wytwórczych w schizofrenii. In: Kozłowska J, Jędrzejewska J, eds. Uczucia i motywacja w psychologii – zbiór wybranych zagadnień. Lublin: Wydawnictwo Naukowe Tygiel; 2022: 165–181 (in Polish).
26.
Frolova NL, Chutko LS, Surushkina, SI. [Neurocirculatory asthenia: psychoautonomic features and treatment possibilities]. Zh Nevropatol Psikhiatr Im S.S. Korsakova 2012; 112: 51–54 (in Russian).
27.
Muthukumar L, Jahangir A, Jan MF, et al. Association between malignant mitral valve prolapse and sudden cardiac death: A review. JAMA Cardiology 2020; 5: 1053–1061.
28.
Sriram CS, Syed FF, Ferguson ME, et al. Malignant Bileaflet Mitral Valve Prolapse Syndrome in Patients with Otherwise Idiopathic Out-of-Hospital Cardiac Arrest. J Am Coll Cardiol 2013; 62: 222–230.
29.
Basso C, Perazzolo Marra M, Rizzo S, et al. Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death. Circulation 2015; 137: 556–566.
30.
Syed FF, Ackerman MJ, McLeod CJ, et al. Sites of successful ventricular fibrillation ablation in bileaflet mitral valve prolapse syndrome. Circ Arrhythm Electrophysiol 2016; 9: e004005.
31.
Boudoulas KD, Pitsis AA, Boudoulas H. Floppy mitral valve (FMV) – Mitral valve prolapse (MVP) – Mitral valvular regurgitation and FMV/MVP syndrome. Hell J Cardiol 2016; 57: 73–85.
32.
Filho AS, Maciel BC, Romano MMD, et al. Mitral valve prolapse and anxiety disorders. Br J Psychiatry 2011; 199: 247–248.
33.
Bayer-Topilsky T, Suri RM, Topilsky Y, et al. Mitral valve prolapse, psychoemotional status, and quality of life: Prospective investigation in the current era. Am J Med 2016; 129: 1100–1109.
34.
Venkatesh A, Pauls DL, Crowe R, et al. Mitral valve prolapse in anxiety neurosis (panic disorder). Br J Psychiatry 1980; 100: 302–305.
35.
Scordo KA. Mitral valve prolapse syndrome: interventions for symptom control. Dimens Crit Care Nurs 1998; 17: 177–186.
36.
Filho AS, Maciel BC, Martin-Santos R, et al. Does the association between mitral valve prolapse and panic disorder really exist? Prim Care Companion J Clin Psychiatry 2008; 10: 38–47.
37.
Lung F-W, Cheng C-T, Chang W-T, et al. Anxiety and mood disorder in young males with mitral valve prolapse. J Multidiscip Healthc 2008; 1: 89–92.
38.
Casey LM, Oei TPS, Newcombe PA. An integrated cognitive model of panic disorder: the role of positive and negative cognitions. Clin Psychol Rev 2004; 24: 529–555.
39.
Gellatly R, Beck AT. Catastrophic Thinking: A Transdiagnostic Process Across Psychiatric Disorders. Cogn Ther Res 2016; 40: 441–452.
40.
Liberthson R, Sheehan DV, King ME, et al. The prevalence of mitral valve prolapse in patients with panic disorders. Am J Psychiatry 1986; 143: 511–515.
41.
Stavrakaki C, Williams E, Boisjoli A, et al. Mitral valve prolapse and psychiatric complications: a case report. J Psychiatr Neurosci 1991; 16: 45–49.
42.
Jankowski P, Kawecka-Jaszcz K, Jastrzębski M. Nowe β-blokery w leczeniu przewlekłej choroby niedokrwiennej serca. Prz Lek 2004; 61: 955–961 (in Polish).
43.
Frohlich ED, Tarazi RC, Dustan HP. Hyperdynamic beta-adrenergic circulatory state. Arch Intern Med 1969; 123: 1–7.
44.
Tyrer P. The role of bodily feelings in anxiety. Maudsley Monograph 1976; 23.
45.
Winkle RA, Lopes MG, Goodman DJ, et al. Propranolol for patients with mitral valve prolapse. Am Heart J 1977; 93: 422–427.
46.
Abinader EG, Shahar J. Excercise testing in mitral valve prolapse before and after beta blockade. Br Heart J 1982; 48: 130–133.
47.
Uyanaeva AI, Tupitsyna YY, Turova EA. et al. The non-medicamentous methods for the prevention and treatment of the patients presenting with neurocirculatory asthenia and concomitant enhanced meteosensitivity. Vopr Kurortol Fizioter Lech Fiz Kult 2017; 94: 4–9.
48.
Masik O, Podolian V, Masik N. Application of client-centered psychotherapy in the complex treatment of adolescents with psychosomatic disorders. Georgian Med News 2019; 296: 55–61.
49.
Riccabona M, Kranz U, Scheer P. An adolescent patient with functional cardiovascular syndrome – treatment with short-term psychotherapy. Padiatr Padol 1993; 28: 137–139.
50.
Kruse J, Joksimovic, L, Cavka M, et al. Effects of trauma-focused psychotherapy upon war refugees. J Trauma Stress 2009; 22: 585–592.
51.
Tessler I, Reshef N, Shpitzen S, et al. Mitral valve prolapse: From new mechanisms to diagnostic challanges. Kardiol Pol 2022; 80: 891–896.
